Cafepharma Today

October 24 2024 - Weight-loss drugs didn't curb health costs within two years
Weight-loss drugs didn't curb health costs within two years
GSK answers Pfizer's RSV approval with data targeting matching nod in younger adults
Why pharma megamergers may become a relic of the past
Lundbeck planning for four novel drugs in phase 3 in 2026
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Elan, Biogen Plunge After Brain Illness Strikes Tysabri Patient
Bloomberg
Thursday, October 30, 2008 - 11:10am
tags:
Johnson & Johnson: Still Adding to My Position
Seeking Alpha
Thursday, October 30, 2008 - 11:09am
tags:
AstraZeneca Beats Forecasts, Raises Year Guidance
CNBC
Thursday, October 30, 2008 - 11:08am
tags:
More R&D: Not Boosting Big Pharma
Businessweek
Thursday, October 30, 2008 - 11:08am
tags:
How Many People Take Cholesterol Drugs?
Forbes
Thursday, October 30, 2008 - 11:06am
tags:
Wyeth Cuts Back Too: Are New Opportunities Being Created?
Seeking Alpha
Thursday, October 30, 2008 - 11:05am
tags:
GlaxoSmithKline to acquire Genelabs Technologies for $57 million, boost hepatitis C efforts
Yahoo/AP
Thursday, October 30, 2008 - 11:04am
tags:
FDA Official: Preemption Argument ‘Based On a False Assumption’
WSJ Online
Thursday, October 30, 2008 - 10:49am
tags:
Wyeth narrowing focus of research to 6 areas, shifting women's health research to new diseases
Yahoo/AP
Thursday, October 30, 2008 - 10:49am
tags:
Biotech funding crisis poses risks to innovation
Guardian, UK
Wednesday, October 29, 2008 - 5:24pm
tags:
Biogen Says Brain Illness Found in Tysabri Patient
Bloomberg
Wednesday, October 29, 2008 - 5:22pm
tags:
Allergan reduces expectations in 2008, and says economic woes will cut 2009 profit growth
Yahoo/AP
Wednesday, October 29, 2008 - 5:22pm
tags:
FDA Objected to Regulation Moves, Rep. Waxman Says
WSJ Online
Wednesday, October 29, 2008 - 5:17pm
tags:
Allergan and Spectrum in bladder cancer drug pact
Yahoo/AP
Wednesday, October 29, 2008 - 4:35pm
tags:
JP Morgan Analyst: Johnson & Johnson Not Worth the Sum of Its Parts
Seeking Alpha
Wednesday, October 29, 2008 - 4:30pm
tags:
Credit Crisis Hits Drugmakers
Motley Fool
Wednesday, October 29, 2008 - 4:28pm
tags:
Improving the Use of Drugs Through Genes
Businessweek
Wednesday, October 29, 2008 - 10:37am
tags:
More big changes for Wyeth
Fierce Pharma
Wednesday, October 29, 2008 - 10:36am
tags:
Grim Outlook for Big Pharma on Capitol Hill
WSJ Online
Wednesday, October 29, 2008 - 10:32am
tags:
Report: US drug sales growth heads toward new low
Yahoo/AP
Wednesday, October 29, 2008 - 10:31am
tags:

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

A Pfight at Pfizer
In the Pipeline
Clinical Trial Volunteers, And Others
In the Pipeline
The 340B Program Reached $66 Billion in 2023—Up 23% vs. 2022: Analyzing the Numbers and HRSA’s Curious Actions
Drug Channels
HCN in Acetonitrile, You Say?
In the Pipeline
Informa Connect’s Trade and Channel Strategies
Drug Channels
AI Does Not Make It Easy
In the Pipeline
The Promise of a Direct-to-Patient Model—Breaking Down What’s Really Needed for Better Patient Access
Drug Channels
Accelerated Approval: What Is It Accomplishing?
In the Pipeline
Cleaning up "Scientific Reports": Can It Be Done?
In the Pipeline

Latest Jobs

Account Manager-Orlando, FL-Ophthalmics
Maitland, Florida, 32794
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Alafaya, Florida
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Union Park, Florida
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Bunker Hill Village, Texas
Sun Pharmaceutical Industries, Inc.
Account Manager-Phoenix, AZ-Oncology
Paradise Valley, Arizona, 85253
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Pasadena, Texas, 77505
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Cloverleaf, Texas
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Gotha, Florida, 34734
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Longwood, Florida, 32791
Sun Pharmaceutical Industries, Inc.
Territory Manager - Medical Dermatology, Richmond VA
Richmond
Sun Pharmaceutical Industries, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information